Percutaneous administration of allogeneic bone-forming cells for the treatment of delayed unions of fractures: a pilot study.

Marc JayankuraArndt Peter SchulzOlivier DelahautRichard WitvrouwLothar SeefriedBruno Vande BergGuy HeynenWendy Sonnet

Published in: Stem cell research & therapy (2021)

NCT02020590 . Registered on 25 December 2013. ALLOB-DU1, A pilot Phase I/IIa, multicentre, open proof-of-concept study on the efficacy and safetyof allogeneic osteoblastic cells (ALLOB®) implantation in non-infected delayed-union fractures.

Keyphrases

induced apoptosis
stem cell transplantation
cell cycle arrest
bone marrow
minimally invasive
clinical trial
study protocol
randomized controlled trial
cell death
oxidative stress
signaling pathway
high dose
cross sectional
body composition